About
Multiple sclerosis is a life-long debilitating auto -immune disease that affects the nerves . Treatment is aimed at controlling the symptoms.
Multiple Sclerosis or MS affects more than a million people worldwide. In India there are 40,000 - 50,000 people estimated to be affected by the disease. It frequently attacks young people usually in the age group of 20-40 years and is more common among females than males.
MS is a crippling disease that starts in the prime of youth. It can cause financial, physical and emotional drain on the family of the patient for many years. It is not a killer disease and the patient has more or less a normal life span but gradually as the condition worsens, the patient is totally disabled and requires managed care.
It was first described in 1835 by French neurologist Jean Charcot. In the initial years the disease has remissions and relapses and typically has a long drawn or chronic course with the person completely recovering from the early symptoms of multiple sclerosis. Relapses or recurrence of the symptoms can occur after initial recovery with each attack consisting of the earlier symptoms or new ones. The symptom pattern, course and severity of the disease vary from person to person.
It has an auto immune origin i.e. the body begins attacking its own nerve fibers, when the fibers become scarred, they give rise to the picture of ‘sclerosis’.
The affected nerve fibers cannot convey signals to and from the brain resulting in loss of sensation, weakness, inability to walk, see or balance oneself, depending on the particular nerve affected by sclerosis.
The diagnosis is made with the help of a typical history, neurological examination and an MRI scan which will show the extent and area of sclerosis.
Treatment for multiple sclerosis consists of medicines to modify the course of the disease, drugs to relieve symptoms, and physical therapy to cope with disability caused by the disease.
What is New in Multiple Sclerosis?
Consuming fish at least once a week or 1 to 3 times per month reduces multiple sclerosis (MS). Two of 13 genetic variations in a human gene cluster that regulates fatty acid levels can lower the risk of MS. Salmon, sardines, albacore, tuna and lake trout are good sources of omega-3 fatty acids. "Consuming fish that contain omega-3 fatty acids has been shown to have a variety of health benefits, and regularly eating fish and taking fish oil supplements, could reduce the risk of MS," said study author Annette Langer-Gould.
Read more >
- Comparison between multiple sclerosis in India and the United States - A case-control study. Bansil S, Singhal BS, Ahuja G K et al. NEUROLOGY 1996; 46: 385-387
- Neurology India-vol 47, issue 1 pg12-7, 1999Syal p, Prabhakar S et al
Please use one of the following formats to cite this article in your essay, paper or report:
-
APA
Dr. Gayatri Krishnan. (2020, January 07). Multiple sclerosis - Symptoms - Causes - Diagnosis - Treatment. Medindia. Retrieved on Sep 28, 2023 from https://www.medindia.net/patients/patientinfo/multiple-sclerosis.htm.
-
MLA
Dr. Gayatri Krishnan. "Multiple sclerosis - Symptoms - Causes - Diagnosis - Treatment". Medindia. Sep 28, 2023. <https://www.medindia.net/patients/patientinfo/multiple-sclerosis.htm>.
Chicago
Dr. Gayatri Krishnan. "Multiple sclerosis - Symptoms - Causes - Diagnosis - Treatment". Medindia. https://www.medindia.net/patients/patientinfo/multiple-sclerosis.htm. (accessed Sep 28, 2023).
Harvard
Dr. Gayatri Krishnan. 2020. Multiple sclerosis - Symptoms - Causes - Diagnosis - Treatment. Medindia, viewed Sep 28, 2023, https://www.medindia.net/patients/patientinfo/multiple-sclerosis.htm.
Latest Publications and Research on Multiple Sclerosis
- In MS: Immunosuppression is passé. - Published by PubMed
- A longitudinal study of cognitive function in multiple sclerosis: is decline inevitable? - Published by PubMed
- Leukocyte profiles in blood and CSF distinguish neurosarcoidosis from multiple sclerosis. - Published by PubMed
- Maraviroc attenuates the pathogenesis of experimental autoimmune encephalitis. - Published by PubMed
- A method to compare prospective and historical cohorts to evaluate drug effects. Application to the analysis of early treatment effectiveness of intramuscular interferon-ß1a in multiple sclerosis patients. - Published by PubMed
i was researching about autoimmune diseases[Multiple Sclerosis to be specific] and current health tech to help curb/manage it and i found this website ww w. naturalherbscentre. com It made a tremendous difference for me I had improved walking balance, muscle strength and improved vision, always thankful for nature that helps in managing these terrible diseases. I’m active now, I can personally vouch for these remedy but you would probably need to decide what works best for you🧡.
After an MRI i was diagnosed of MULTIPLE SCLEROSIS. After years on medications, symptoms worsened with tremors on my right hand, numbness and tingling, muscle weakness and loss of speech. Fortunately last year, i learnt about Health Herbs Clinic and their Multiple Sclerosis alternative treatment [ww w. healthherbsclinic. com], the Multiple Sclerosis treatment made a great difference, most of my symptoms including tremors, weakness and others gradually disappeared. I improved greatly over the 6 months treatment, its been a years since the treatment, i have no symptoms. I have a very good quality of life and a supportive family!
I was diagnosed in 1996, before symptoms started. I am a pianist, suddenly unable to open my hands wide enough to get 8 keys. Nobody in my family had MS, nor my grandparents. Last year a cousin younger than me had MS, she is 40. I have primary progressive MS. I do not walk for the last 18 years, I was born in 1962. I have had 6 strokes and 1 heart attack.The Rebif [beta-1a] did very little to help me. The medical team did even less. After roughly five unending years of trauma in the family my MS developed into progressive. There have been many changes in the last 3 to 4 years. Many falls, many fractured bones, and three moves all in five years. I have gone downhill. Considerably. We tried every shot available but nothing was working. There has been little if any progress in finding a reliable treatment for Multiple Sclerosis, My care provider Dr Miller introduced me to Kycuyu Health Clinic and their MS herbal treatment. The treatment is a miracle! I Adhere anyone reading this to try natural approach. visit www. kycuyuhealthclinic . c o m
hii, Me interested in seeking hsct[stem cell transplant] from India.me with rrms 5years post disease activity.Any one who has ms in India would be pyscological help for me.Please responds. Regards shaik
Chronic cerebrospinal venous insufficiency [CCSVI], or the pathological restriction of venous vessel discharge from the CNS has been proposed by Zamboni, et al, as having a correlative relationship to Multiple Sclerosis. From a clinical perspective, it has been demonstrated that the narrowed jugular veins in an MS patient, once widened, do affect the presenting symptoms of MS and the overall health of the patient. It has also been noted that these same veins once treated, restenose after a time in the majority of cases. Why the veins restenose is speculative. One insight, developed through practical observation, suggests that there are gaps in the therapy protocol as it is currently practiced. In general, CCSVI therapy has focused on directly treating the venous system and the stenosed veins. Several other factors that would naturally affect vein recovery have received much less consideration. As to treatment for CCSVI, it should be noted that no meaningful aftercare protocol based on evidence has been considered by the main proponents of the ‘liberation’ therapy (neck venoplasty). In fact, in all of the clinics or hospitals examined for this study, patients weren’t required to stay in the clinical setting any longer than a few hours post-procedure in most cases. Even though it has been observed to be therapeutically useful by some of the main early practitioners of the ‘liberation’ therapy, follow-up, supportive care for recovering patients post-operatively has not seriously been considered to be part of the treatment protocol. To date, follow-up care has primarily centered on when vein re-imaging should be done post-venoplasty. The fact is, by that time, most patients have restenosed (or partially restenosed) and the follow-up Doppler testing is simply detecting restenosis and retrograde flow in veins that are very much deteriorated due to scarring left by the initial procedure. This article discusses a variable approach as to a combination of safe and effective interventional therapies that have been observed to result in enduring venous drainage of the CNS to offset the destructive effects of inflammation and neurodegeneration, and to regenerate disease damaged tissue.
Follow @MedIndia